Literature DB >> 7629542

Treatment of severe tetanus by continuous intrathecal infusion of baclofen.

H Brock, W Moosbauer, C Gabriel, S Necek, D Bidal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7629542      PMCID： PMC486003          DOI： 10.1136/jnnp.59.2.193

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Flumazenil counteracts intrathecal baclofen-induced central nervous system depression in tetanus.

Authors:  J M Saissy; M Vitris; J Demazière; M Seck; L Marcoux; M Gaye
Journal:  Anesthesiology       Date:  1992-06       Impact factor: 7.892

2.  Reversible coma due to intrathecal baclofen.

Authors:  J A Romijn; J J van Lieshout; D N Velis
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

3.  Continuous intrathecal baclofen for severe spasticity.

Authors:  R D Penn; J S Kroin
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321
  3 in total
  1 in total

Review 1.  Pharmacological management of tetanus: an evidence-based review.

Authors:  Chaturaka Rodrigo; Deepika Fernando; Senaka Rajapakse
Journal:  Crit Care       Date:  2014-03-26       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.